You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Title |
Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
|
---|---|
Published in |
Trials, August 2022
|
DOI | 10.1186/s13063-022-06649-3 |
Pubmed ID | |
Authors |
Anan Manomaipiboon, Kittisak Pholtawornkulchai, Sujaree Poopipatpab, Swangjit Suraamornkul, Jakravoot Maneerit, Wiroj Ruksakul, Uraporn Phumisantiphong, Thananda Trakarnvanich |
X Demographics
The data shown below were collected from the profiles of 161 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 19 | 12% |
Japan | 19 | 12% |
Australia | 1 | <1% |
Comoros | 1 | <1% |
Germany | 1 | <1% |
Dominican Republic | 1 | <1% |
France | 1 | <1% |
Austria | 1 | <1% |
Unknown | 117 | 73% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 155 | 96% |
Scientists | 3 | 2% |
Practitioners (doctors, other healthcare professionals) | 2 | 1% |
Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 30 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 3 | 10% |
Other | 2 | 7% |
Student > Master | 2 | 7% |
Lecturer | 1 | 3% |
Student > Ph. D. Student | 1 | 3% |
Other | 1 | 3% |
Unknown | 20 | 67% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 17% |
Business, Management and Accounting | 2 | 7% |
Engineering | 1 | 3% |
Unknown | 22 | 73% |